SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001213900-20-028595
Filing Date
2020-09-28
Accepted
2020-09-28 11:29:10
Documents
13

Document Format Files

Seq Description Document Type Size
1 f424b40920_greenwichlifesci.htm 424B4 3125222
2 GRAPHIC greenwich_logo.jpg GRAPHIC 98426
3 GRAPHIC image_001.jpg GRAPHIC 545751
4 GRAPHIC image_002.jpg GRAPHIC 320220
5 GRAPHIC image_003.jpg GRAPHIC 225634
6 GRAPHIC image_004.jpg GRAPHIC 333744
7 GRAPHIC image_005.jpg GRAPHIC 115277
8 GRAPHIC image_006.jpg GRAPHIC 131870
9 GRAPHIC image_007.jpg GRAPHIC 352923
10 GRAPHIC image_008.jpg GRAPHIC 919812
11 GRAPHIC image_009.jpg GRAPHIC 931368
12 GRAPHIC image_010.jpg GRAPHIC 198882
13 GRAPHIC image_011.jpg GRAPHIC 189534
  Complete submission text file 0001213900-20-028595.txt   9109956
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

IRS No.: 205473709 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-238829 | Film No.: 201202801
SIC: 2834 Pharmaceutical Preparations